期刊文献+

静电吸附法与生物素-亲和素桥联法制备PSMA抗体靶向纳米微泡的对比实验研究 被引量:4

Contrast experimental study on preparation of PSMA-targeted nanobubbles using electrostatic adsorption method and biotin avidin-bridging technology
在线阅读 下载PDF
导出
摘要 目的比较静电吸附法和生物素-亲和素桥联法制备前列腺特异性膜抗原(PSMA)抗体靶向纳米微泡的物理特性和靶向黏附率。方法分别应用静电吸附法和生物素-亲和素桥联法制备PSMA抗体靶向的纳米微泡,检测其物理性状;光镜下观察两种微泡与前列腺癌细胞LNCaP和C4-2的靶向能力,并与胃癌细胞MKN45对照;对比分析两种靶向纳米微泡的粒径、浓度及与前列腺癌细胞结合能力。结果两种靶向纳米微泡均呈圆形,表面光滑,大小均匀,分散度好,无聚集,粒径均<1000 nm。静电吸附法制备的靶向纳米微泡平均粒径为(702.96±66.65)nm,平均浓度为(3.46±0.30)×108/ml,与前列腺癌细胞LNCaP黏附率(77.2±3.19)%,与C4-2细胞黏附率(61.00±4.47)%;生物素-亲和素桥联法制备的靶向纳米微泡平均粒径为(609.90±37.40)nm,平均浓度约(4.52±0.19)×108/ml,与前列腺癌细胞LNCaP黏附率(96.60±1.14)%,与C4-2细胞黏附率(94.00±1.58)%。两种靶向纳米微泡的粒径、浓度及与前列腺癌细胞黏附率比较,差异均有统计学意义(均P<0.05);与胃癌细胞MKN45均无黏附。结论生物素-亲和素桥联法是一种高效、灵敏、稳定、特异性强的PSMA抗体靶向微泡制备方法,较静电吸附法具有更大的优势。 Objective To compare the characteristics and adhesion rate of PSMA-targeted nanobubbles prepared using electrostatic adsorption method and biotin avidin-bridging technology. Methods PSMA monoclonal antibody-loaded targeted nanobubbles were prepared using electrostatic adsorption technology and biotin-avidin bridging technology. Their general characteristics were detected. Using MKN45 gastric cancer cells as the control, the targeting capability of the targeted nanobubbles to prostate cancer cells (LNCaP and C4-2) was observed under optical microscope. The differences between the two kinds of targeted nanobubbles in particle size, stability, and the ability adhered to prostate cancer cells was analyzed. Results The two kinds of targeted nanobubbles were round and had the uniform size with good dispersity and no aggregation. The average particle size of PSMA-targeted nanobubble prepared with electrostatic adsorption was (702.96±66.65)nm, concentration was about (3.46_+0.30) ×10^8/ml, and prostate cancer cells LNCaP adhesion rate was (77.2±3.19)%, and C4-2 cell adhesion rate was (61.00±4.47 )%; while the average particle size of PSMA-targeted nanobubble prepared with avidinbiotin complex technology was (609.90±37.40)nm, concentration was about (4.52±0.19) ×10^8/ml, and prostate cancer cells LNCaP adhesion rate was ( 96.60± 1.14)%, and C4-2 cell adhesion rate was (94.00±1.58)%. The differences of particle size, concentration and cell adhesion rate of the two kinds of targeted microbubble were statistically significant(P〈0.05 ). The two kinds of nanobubbles were not adhered to MKN45 gastric cancer cells. Conclusion Biotin-avidin bridging method has more advantages than electrostatic adsorption method in preparation of PSMA-targeted nanobubbles. It is an efficient, sensitive, stable, specific method.
出处 《临床超声医学杂志》 2013年第12期809-812,共4页 Journal of Clinical Ultrasound in Medicine
基金 国家自然科学基金(30970830) 重庆市科委自然科学基金(cstc2012jjB10072)
关键词 靶向微泡 前列腺特异性膜抗原 静电吸附法 生物素-亲和素系统 Targeted microbubbles Prostate-specific membrane antigen Electrostatic adsorption Biotin-avidin system
  • 相关文献

参考文献3

二级参考文献23

共引文献7

同被引文献25

  • 1张军,马远方,刘广超,吴雄文.死亡受体5在肝癌细胞系及肝细胞系表面的表达[J].中国肿瘤临床,2006,33(5):287-289. 被引量:5
  • 2Rapoport N, Christensen DA, Kennedy AM. Cavitation proper- ties of block copolymer stabilized phase-shift nanoemulsions used as drug carriers. Ultrasound Med Biol, 2010,36(3) :419-429.
  • 3Wiley SR, Schooley K, Smolak PJ, et al. Identification and char- acterization of a new member of the TNF family that induces ap- optosis. Immunity, 1995,3(6):67368g.
  • 4Cha SS, Sung BJ, Kim YA, et al. Crystal structure of TRAIL- DR5 complex identifies a critical role of the unique rame insertion in conferring recognition specificity. J Biol Chem, 2000,275(40) : 31171-31177.
  • 5Piechocki MP, Wu GS, Jones RF, et al. Induction of proapoptot- ic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor Dr5 DNA. Int J Cancer, 2012,131 (11) : 2562-2572.
  • 6Cyrus T, Winter PM, Caruther SD, et al. Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy. Exper Rev Cardiovasc Ther, 2005,3(4) :705-715.
  • 7Vaneycken I, D'huyvetter M, Hernot S, et al. Immuno-imaging using nanobodies. Curt Opin Biotechnol, 2011,22(6) :877-881.
  • 8孔莺,聂艳丽,南克俊.奥沙利铂处理HepG2细胞后DR5、caspase-8及survivin、bcl-2表达的变化[J].现代肿瘤医学,2010,18(4):650-654. 被引量:4
  • 9曹亿(综述),郭正辉(审校).靶点PSMA在前列腺癌中诊断治疗的研究进展[J].国际泌尿系统杂志,2010,30(6):758-761. 被引量:1
  • 10寇军燕,张沂平.TRAIL的抗肿瘤机制及其应用[J].中华肿瘤防治杂志,2010,17(22):1892-1895. 被引量:2

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部